Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.00
0.115.82%
Last update: Oct 5, 7:19 AM
$2.01
0.126.37%
Cabaletta Bio Inc (CABA) Stock Price, Quote, News & History
CABANASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Cabaletta Bio (NASDAQ:CABA) through any online brokerage.
Other companies in Cabaletta Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Cabaletta Bio has a consensus price target of $19.91.
The stock price for Cabaletta Bio (NASDAQ: CABA) is $2.0104 last updated October 5, 2026 at 7:19 AM EDT.
There are no upcoming dividends for Cabaletta Bio.
Cabaletta Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Cabaletta Bio.
Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
